학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 7건 | 목록
1~20
Academic Journal
Spiekman, Ilse A C; Geurts, Birgit S; Zeverijn, Laurien J; Wit, Gijs F de; van der Noort, Vincent; Roepman, Paul; Leng, Wendy W J de; Jansen, Anne M L; Kusters, Benno; Beerepoot, Laurens V; Vos, Filip Y F L de; Groot, Derk-Jan A de; Groot, Jan Willem B de; Hoeben, Ann; Buter, Jan; Gelderblom, Hans A J; Voest, Emile E; Verheul, Henk M W
Oncologist; May2024, Vol. 29 Issue 5, p431-440, 10p
Academic Journal
Spiekman IAC; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, the Netherlands.; Mehra N; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Zeverijn LJ; Department of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Geurts BS; Department of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Verkerk K; Department of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Haj Mohammad SF; Department of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.; van der Noort V; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Roepman P; Hartwig Medical Foundation, Amsterdam, the Netherlands.; de Leng WWJ; Department of Pathology, University Medical Cancer Center Utrecht, Utrecht, the Netherlands.; Jansen AML; Department of Pathology, University Medical Cancer Center Utrecht, Utrecht, the Netherlands.; van de Luijtgaarden ACM; Department of Medical Oncology, Reinier de Graaf Hospital, Delft, the Netherlands.; van Voorthuizen T; Department of Medical Oncology, Rijnstate, Arnhem, the Netherlands.; Buffart TE; Department of Medical Oncology, Amsterdam University Medical Center, location VUMC, Cancer Center, Amsterdam, the Netherlands.; Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.; Voest EE; Department of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Verheul HMW; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, the Netherlands.
Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE
Academic Journal
Haj Mohammad SF; Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, Leiden 2333 ZG, the Netherlands; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, the Netherlands.; Spiekman IAC; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, Rotterdam 3015 CP, the Netherlands.; Verkerk K; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, the Netherlands; Oncode Institute, Jaarbeursplein 6, Utrecht 3521 AL, the Netherlands.; Verbeek FAJ; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, the Netherlands; Oncode Institute, Jaarbeursplein 6, Utrecht 3521 AL, the Netherlands.; Timmer H; Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, Leiden 2333 ZG, the Netherlands; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, the Netherlands.; van Maren MA; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, Rotterdam 3015 CP, the Netherlands.; Zeverijn LJ; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, the Netherlands; Oncode Institute, Jaarbeursplein 6, Utrecht 3521 AL, the Netherlands.; Geurts BS; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, the Netherlands; Oncode Institute, Jaarbeursplein 6, Utrecht 3521 AL, the Netherlands.; Daletzakis A; Biometrics Department, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, the Netherlands.; Roepman P; Hartwig Medical Foundation, Science Park 404, Amsterdam 1098 XH, the Netherlands.; Jansen AML; Department of Pathology, University Medical Cancer Center Utrecht, Heidelberglaan 100, Utrecht 3584 CX, the Netherlands.; de Leng WWJ; Department of Pathology, University Medical Cancer Center Utrecht, Heidelberglaan 100, Utrecht 3584 CX, the Netherlands.; Maas SLN; Department of Pathology, Leiden University Medical Center, Albinusdreef 2, Leiden 2333 ZG, the Netherlands; Department of Pathology, Brain Tumor Center, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, Rotterdam 3015 CP, the Netherlands.; de Vos FYFL; Department of Medical Oncology, University Medical Cancer Center Utrecht, Heidelberglaan 100, Utrecht 3584 CX, the Netherlands.; Verheul HMW; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, Rotterdam 3015 CP, the Netherlands.; Voest EE; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, the Netherlands; Oncode Institute, Jaarbeursplein 6, Utrecht 3521 AL, the Netherlands.; Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, Leiden 2333 ZG, the Netherlands. Electronic address: a.j.gelderblom@lumc.nl.
Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Academic Journal
Verkerk K; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Haj Mohammad SF; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.; Zeverijn LJ; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Geurts BS; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Spiekman IAC; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Verbeek FAJ; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Timmer H; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.; van Maren MA; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; van der Noort V; Biometrics Department, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Parra-Martinez M; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Roepman P; Hartwig Medical Foundation, Amsterdam, the Netherlands.; Jansen AML; Department of Pathology, University Medical Cancer Center Utrecht, Utrecht, the Netherlands.; de Leng WWJ; Department of Pathology, University Medical Cancer Center Utrecht, Utrecht, the Netherlands.; Marchetti S; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Monkhorst K; Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Verheul HMW; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.; Voest EE; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Haj Mohammad SF; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands; Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands. s.f.haj_mohammad@lumc.nl.; Timmer HJL; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands; Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Zeverijn LJ; Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Geurts BS; Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Spiekman IAC; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Verkerk K; Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Verbeek FAJ; Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Verheul HMW; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Voest EE; Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.
Publisher: Medical Journals Sweden AB Country of Publication: Sweden NLM ID: 8709065 Publication Model: Electronic Cited Medium: Internet ISSN: 1651-226X (Electronic) Linking ISSN: 0284186X NLM ISO Abbreviation: Acta Oncol Subsets: MEDLINE
Academic Journal
Verkerk K; Department of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; van der Wel TJWT; Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Zeverijn LJ; Department of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Geurts BS; Department of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Spiekman IAC; Oncode Institute, Utrecht, the Netherlands.; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, the Netherlands.; de Wit GF; Department of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Roepman P; Hartwig Medical Foundation, Amsterdam, the Netherlands.; Jansen AML; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.; van der Noort V; Biometrics Department, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Smit EF; Department of Pulmonology, Leiden University Medical Center, Leiden, the Netherlands.; Hoeben A; Division of Medical Oncology, Department of Internal Medicine, GROW School of Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands.; Hendriks LEL; Department of Pulmonology, GROW - School for Oncology and Reproduction, Maastricht University Medical Center, Maastricht, the Netherlands.; van den Heuvel MM; Department of Pulmonary Diseases, Radboud University Medical Center, Nijmegen, the Netherlands.; Piet B; Department of Pulmonary Diseases, Radboud University Medical Center, Nijmegen, the Netherlands.; Herder GJM; Department of Pulmonology, Meander Medical Center, Amersfoort, the Netherlands.; Hashemi SMS; Department of Pulmonary Medicine, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, the Netherlands.; Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.; Verheul HMW; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, the Netherlands.; Voest EE; Department of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Center for Personalized Cancer Treatment, the Netherlands.; de Langen AJ; Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Spiekman IAC; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, the Netherlands.; Zeverijn LJ; Oncode Institute, Utrecht, the Netherlands; Department of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Geurts BS; Oncode Institute, Utrecht, the Netherlands; Department of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Verkerk K; Oncode Institute, Utrecht, the Netherlands; Department of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Haj Mohammad SF; Department of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.; van der Noort V; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Roepman P; Hartwig Medical Foundation, Amsterdam, the Netherlands.; de Leng WWJ; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.; Jansen AML; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.; Gootjes EC; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; de Groot DA; Department of Medical Oncology, University Medical Center Groningen, Groningen, the Netherlands.; Kerver ED; Department of Medical Oncology, OLVG, Amsterdam, the Netherlands.; van Voorthuizen T; Department of Medical Oncology, Rijnstate, Arnhem, the Netherlands.; Roodhart JML; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, the Netherlands.; Valkenburg-van Iersel LBJ; Division of Medical Oncology, Department of Internal Medicine, GROW school of Oncology and Development Biology, Maastricht University Center+, Maastricht, the Netherlands.; Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.; Voest EE; Oncode Institute, Utrecht, the Netherlands; Department of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Verheul HMW; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, the Netherlands. Electronic address: h.verheul@erasmusmc.nl.
Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Spiekman, Ilse A C
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어